R Lagnaoui

Summary

Country: France

Publications

  1. ncbi Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability
    R Lagnaoui
    Department of Pharmacology, Universite Victor Segalen, Bordeaux, France
    Eur J Clin Pharmacol 56:181-6. 2000
  2. ncbi Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates
    R Lagnaoui
    Departement de Pharmacologie, Universite Victor Segalen, Bordeaux 2, 33 076 Bordeaux, France
    Pharmacoepidemiol Drug Saf 10:531-5. 2001
  3. ncbi Benzodiazepine use and risk of dementia: a nested case-control study
    Rajaa Lagnaoui
    Departement de Pharmacologie, Universite Victor Segalen, Bordeaux 2, 33 076 Bordeaux, France
    J Clin Epidemiol 55:314-8. 2002
  4. ncbi Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects
    N Moore
    Department of Pharmacology, Universite Victor Segalen, Bordeaux, France
    Clin Pharmacol Ther 69:445-50. 2001
  5. ncbi Benzodiazepines and hip fractures in elderly people: case-control study
    C Pierfitte
    , , Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux Cedex, France
    BMJ 322:704-8. 2001

Collaborators

Detail Information

Publications5

  1. ncbi Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability
    R Lagnaoui
    Department of Pharmacology, Universite Victor Segalen, Bordeaux, France
    Eur J Clin Pharmacol 56:181-6. 2000
    ..To increase the knowledge base, we did a study of the frequency, hazard function, avoidability, and cost of ADRs as a cause for admission in internal medicine, or when occurring after admission...
  2. ncbi Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates
    R Lagnaoui
    Departement de Pharmacologie, Universite Victor Segalen, Bordeaux 2, 33 076 Bordeaux, France
    Pharmacoepidemiol Drug Saf 10:531-5. 2001
    ....
  3. ncbi Benzodiazepine use and risk of dementia: a nested case-control study
    Rajaa Lagnaoui
    Departement de Pharmacologie, Universite Victor Segalen, Bordeaux 2, 33 076 Bordeaux, France
    J Clin Epidemiol 55:314-8. 2002
    ..0; 95% CI, 0.6-1.6). Our finding suggest that former use of benzodiazepines could be a risk factor for dementia, but more detailed investigation are needed...
  4. ncbi Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects
    N Moore
    Department of Pharmacology, Universite Victor Segalen, Bordeaux, France
    Clin Pharmacol Ther 69:445-50. 2001
    ..This study endeavored to compare sources of information on current exposure to benzodiazepines in elderly subjects...
  5. ncbi Benzodiazepines and hip fractures in elderly people: case-control study
    C Pierfitte
    , , Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux Cedex, France
    BMJ 322:704-8. 2001
    ..1 to 3.1). CONCLUSION: Except for lorazepam, the presence of benzodiazepines in plasma was not associated with an increased risk of hip fracture. The method used to ascertain exposure could influence the results of case-control studies...